Thousands of men battling prostate cancer are set to gain access to a life-extending drug on the NHS following a significant ...
University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer ...
A life-extending prostate cancer drug is to be made available to thousands of men in England in a matter of weeks, after a ...
News-Medical.Net on MSN
PSA-based tool improves decision making for prostate cancer screening and treatment
In a previous study, the researchers showed that PSA scores can impact both doctor and patient behavior, leading to biopsy ...
Join Tom and Mike as they share an important update on Tom's prostate cancer journey. In this video, they discuss Tom's ...
Around 55,000 new cases of prostate cancer are diagnosed in the UK every year, and super drug abiraterone will offer hope to ...
Thousands of men with prostate cancer will be offered a life-extending drug on the NHS within weeks. For the first time patients whose prostate cancer has not spread will be able to receive the drug ...
NHS England has announced that men whose high-risk prostate cancer has not yet spread will be able to receive the drug, ...
Thousands of men with prostate cancer will be given a life-extending drug on the NHS, following a three-year battle to expand ...
Men with high‑risk locally advanced prostate cancer in England will soon be offered the drug abiraterone on the NHS, ...
Cancer survival in the U.S. has climbed to 70%, reflecting major advances in treatment, early detection and personalized care ...
News-Medical.Net on MSN
Study tests combined targeted radiopharmaceuticals and precision radiation for recurrent prostate cancer
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have opened a clinical trial that will look at whether ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results